The First Real Marijuana Stock Registration? Bud Genius in Talks to List Subsidiary on OTC:BB
August 22 2014 - 8:37AM
Business Wire
The board of directors of Bud Genius (Symbol: RIGH) yesterday
began discussion on filing an S-1 registration for its new
subsidiary, Genius Biotech Corporation, to be listed on the OTC:BB,
following a full audit.
Company CEO, Angel Stanz, had this to say, “We want to be a
respectable publicly traded company. We already provide reliable
information to doctors and patients about medical marijuana. By now
it is key to set us apart from the rest of the industry as a leader
with the highest standards. Aside from laboratory testing and
certification, we believe our company may best be represented with
a registration of our shares. We have hired an advisory firm to
help us determine the value of our new company, to weigh the
benefits, and to help us determine if this is going to be a good
thing. Such a registration could benefit our shareholders, and help
provide a higher level of credibility to quality leaders working
with laboratory-grade medical marijuana.
Some have told us that this would be the first registration of a
real marijuana industry stock because we are part of the true core
of the industry by actually handling and testing marijuana, as
opposed to just selling support products to others. I don’t know if
that is accurate, but Genius Biotech Corporation will be providing
a lot more industry firsts than this in terms of integrity and
reliability as our nation moves closer to what could be some major
changes. We were one of the first in this space and we will
continue to stay at the forefront. There are a lot of fantastic
companies out there, and people will be looking at us to be the
fair judge of laboratory standards. We applaud the SEC’s crackdown
on the marijuana industry. It was needed and we hope by our
registration to be an example for other companies to follow.”
Limited information about the new company is available at this
time, and more information about the company will be provided in
the company’s registration at the time of its completion, or on the
company’s website after it has been announced.
About Bud GeniusAn early leader in an industry that many
are speculating will grow, Bud Genius is one of the first
established analytical cannabis laboratories in the United States.
Bud Genius was launched to bring vendors together with doctors,
patients, and dispensaries that require certified products held to
demanding standards. Bud Genius has a vision to expand across the
US and abroad serving as the beacon of quality for medical cannabis
and adult-use marijuana through the formation of regional
laboratories. Certification, data collection, and online reports
are the measure by which the company gains.
For more information please visit:http://www.BudGenius.com
The foregoing press announcement contains forward-looking
statements that can be identified by such terminology such as
"believes," "expects," "potential," "plans," "suggests," "may,"
"should," "could," "intends," or similar expressions. Such
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results
to be materially different from any future results, performance or
achievements expressed or implied by such statements. In
particular, management's expectations could be affected by, among
other things, uncertainties relating to our success in completing
acquisitions, financing our operations, entering into strategic
partnerships, engaging management and other matters disclosed by us
in our public filings from time to time. Forward-looking statements
speak only as to the date they are made. The Company does not
undertake to update forward-looking statements to reflect
circumstances or events that occur after the date the
forward-looking statements are made.
Bud GeniusAngel Stanz, Chief Executive
Officer855-723-3283PR@BudGenius.com
RightSmile (CE) (USOTC:RIGH)
Historical Stock Chart
From Aug 2024 to Sep 2024
RightSmile (CE) (USOTC:RIGH)
Historical Stock Chart
From Sep 2023 to Sep 2024